Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Bristol-Myers Squibb Company (NYSE: BMY)
BMY Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
2.80%
Analyst Rating:
BUY
Analyst Forecast (1yr):
12.30%
BMY Stock Analysis
BMY
PE Ratio:
15.4
BMY
PEG Ratio:
-6.1
BMY
Forward EPS Growth (12 month):
-2.50%
BMY
PS Ratio:
2.3
BMY
PSG Ratio:
-1.1
BMY
Forward Revenue Growth (12 month):
-2.10%
BMY Articles
No data was found